niclosamide has been researched along with Community Acquired Infection in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marrugal-Lorenzo, JA | 1 |
| Serna-Gallego, A | 1 |
| Berastegui-Cabrera, J | 1 |
| Pachón, J | 1 |
| Sánchez-Céspedes, J | 1 |
1 other study available for niclosamide and Community Acquired Infection
| Article | Year |
|---|---|
Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections.
Topics: A549 Cells; Adenoviridae; Adenoviridae Infections; Antiviral Agents; Community-Acquired Infections; | 2019 |